Sahak, Judith C.
HRN: 07-33-15 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/30/2022
MEBENDAZOLE 50MG/ML, 60ML SUSPENSION (BOT)
06/30/2022
07/06/2022
ORAL
5ml
BID
SE: Ascaris, T.trichiura
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes